re takeover potential....i believe amro's prediction is definately in the right sector , however i believe it would more likely be a generic drug company than csl.......'big pharma' is drying up and the real growth comes from the generics side....80 billion [yes thats right] worth of drugs come of patent over the next 2-3 years worldwide and 2 billion in australia.......aggregate pharmaceutical sales were declining on originator molucules after experiencing double digit growth through the 80's and 90's . Generic companies especially in india are desperate to grow their businesses in new countries [ranbaxy , cipla and dr reddy's]...just have a look at the t/overs and aq list over the last 2 years [like no other sector] Then there is the case that big pharma may need their own generic arm to stay viable ......interesting to see who gets swallowed up over the next year or two
- Forums
- ASX - By Stock
- CSL
- a fantastic short.
a fantastic short., page-28
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$300.26 |
Change
-1.400(0.46%) |
Mkt cap ! $145.3B |
Open | High | Low | Value | Volume |
$303.31 | $303.47 | $299.56 | $148.6M | 498.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 276 | $300.19 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$300.34 | 1250 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 250 | 300.000 |
1 | 99 | 299.950 |
1 | 5 | 299.650 |
1 | 6 | 299.500 |
2 | 32 | 299.100 |
Price($) | Vol. | No. |
---|---|---|
300.650 | 59 | 1 |
301.160 | 55 | 1 |
301.660 | 35 | 1 |
301.890 | 19 | 1 |
302.000 | 53 | 2 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online